Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 428 resultados
LastUpdate Última actualización 03/08/2026 [08:07:00]
pdfxls
Solicitudes publicadas en los últimos 30 días / Applications published in the last 30 days
previousPage Resultados 375 a 400 de 428 nextPage  

3 METHOD AND DEVICE FOR OUTPUTTING A 3D PRINTING OUTPUT USING SETTINGS FOR OUTPUTTING A FRACTURE MODEL

NºPublicación:  KR20260108808A 09/07/2026
Solicitante: 
백석문화대학교산학협력단

Resumen de: KR20260108808A

일 실시예에 따른 출력 장치는 환자의 골절 부위를 촬영하여 생성된 CT 데이터를 수집하는 단계; 상기 수집된 CT 데이터를 이용하여 소정의 조직에 대응하는 3차원 출력을 위한 골절 모델을 생성하는 단계; 상기 생성된 골절 모델을 분할하는 단계; 상기 분할된 골절 모델을 출력하기 위한 설정값을 결정하는 단계; 및 상기 결정된 설정값에 기초하여 상기 분할된 골절 모델의 3차원 출력물을 출력하는 단계를 수행할 수 있다.

SUPPORT MATERIAL FORMULATIONS USABLE IN ADDITIVE MANUFACTURING AND METHODS EMPLOYING SAME

NºPublicación:  WO2026146504A2 09/07/2026
Solicitante: 
STRATASYS LTD [IL]
STRATASYS LTD.
WO_2026146504_A2

Resumen de: WO2026146504A2

A curable formulation usable as a support material formulation in additive manufacturing of a three-dimensional object such as a denture structure, which forms a hardened mixed layer with a modeling material formulation and provides an object that features improved toughness (e.g., fracture toughness), and additive manufacturing methods employing same are provided. The curable formulation comprises at least one non-curable material which comprises at least one polymeric material featuring water solubility (e.g., ECAH) lower than 200 grams/liter, at least one mono-functional (meth)acrylate featuring low Tg and miscibility in the non-curable material, at least one multi-functional (meth) acrylate featuring at least 10 ethoxylated groups and/or Tg lower than 0 °C, and at least one mono-functional (meth)acrylate. Additive manufacturing of a three- dimensional assembly which comprises a hardened object and a hardened sacrificial structure, and systems employing same are also provided.

SCALABLE FLUIDIC DEVICES FOR HIGH-THROUGHPUT ENRICHMENT AND SEPARATION OF CHARGED SPECIES AND METHODS OF USE

NºPublicación:  US20260192217A1 09/07/2026
Solicitante: 
IOWA STATE UNIV RESEARCH FOUNDATION INC [US]
Iowa State University Research Foundation, Inc.
US_20260192217_A1

Resumen de: US20260192217A1

The present disclosure relates generally to fluidic devices for high-throughput removal of charged particles from a fluid, for example contaminants from drinking water or contaminants from spent dialysate. The fluidic devices comprise a flow-through 3D ion selective structure within a channel for focusing charged particles along an electric field gradient at the boundary of an ion depleted zone and/or in an ion enriched zone created by the 3D ion selective structure, thereby removing said charged particles from the fluid flowing through the 3D ion selective structure.

MONITORING SYSTEM ENHANCED WITH MILLIMETER-WAVE SENSING

NºPublicación:  WO2026148222A1 09/07/2026
Solicitante: 
NOMO INT INC [US]
NOMO INTERNATIONAL, INC.
WO_2026148222_A1

Resumen de: WO2026148222A1

Methods, devices and systems for monitoring a home or other environments, including detection of activities related to movement of a person within a home environment, are described. An example monitoring system includes a hub device communicably coupled to a plurality of sensor devices deployed in an area and configured to collect sensor data for the area. At least one of the sensor devices includes a millimeter-wave (mmWave) sensing component configured to generate three-dimensional sensor data based on the transmission of mmWave signals, which enables the monitoring system to detect normal and abnormal activities as well as non-activities, within the monitored environment.

STRETCHABLE AND HIGHLY CONDUCTIVE CRUMPLED GRAPHENE-BASED FILMS FOR MULTIFUNCTIONAL APPLICATIONS

NºPublicación:  US20260193139A1 09/07/2026
Solicitante: 
THE PENN STATE RES FOUNDATION [US]
The Penn State Research Foundation
US_20260193139_A1

Resumen de: US20260193139A1

Embodiments relate to a nanocomposite material including a graphene-based 3D porous scaffold coated with active nanoparticles and to methods of making and using the material. The nanocomposite material exhibits high electrical conductivity, mechanical stretchability, and surface roughness, achieved through laser scribing, electrodeposition, and pre-strain transfer printing to induce crumpling. Embodiments further relate to a device including a crumpled nanocomposite material as an electrode and to methods of making and using the device.

ELECTRONIC STETHOSCOPE AND MULTI-SENSOR SYSTEM FOR TELEMEDICINE

NºPublicación:  WO2026147853A1 09/07/2026
Solicitante: 
PETROZZINO JEFFREY [US]
PETROZZINO, Jeffrey
WO_2026147853_A1

Resumen de: WO2026147853A1

A biosensor system for telemedicine and remote physiological monitoring is provided. The biosensor system may include a sensor subsystem comprising a piezoelectric film sensor configured to detect and transduce human or animal body acoustics into electrical signals. The biosensor system may include an electronics subsystem removably coupled to the sensor subsystem. The electronics subsystem may include an interface for interacting with the sensor subsystem, pre-processing circuitry for generating a pre-processed signal from a signal received from the sensor subsystem, a processor configured to receive the pre-processed signal, a communications interface operably coupled to the processor and configured to send the preprocessed signal to a receiving device, and a power supply configured to provide power to the biosensor system. The pre-processing circuitry may include a preamp and a filter.

PATIENT STRATIFICATION

NºPublicación:  WO2026147825A1 09/07/2026
Solicitante: 
STAMFORD PHARMACEUTICALS INC [US]
STAMFORD PHARMACEUTICALS INC.
WO_2026147825_A1

Resumen de: WO2026147825A1

The present invention relates generally to the fields of cancer therapy and patient stratification. More particularly, the specification relates to determining a likelihood of a patient response to cancer treatment.

SYSTEMS AND METHODS FOR MONITORING OXIMETRY PARAMETERS OF TISSUE

NºPublicación:  US20260191440A1 09/07/2026
Solicitante: 
NIRSENSE INC [US]
NIRSense, Inc.
US_20260191440_A1

Resumen de: US20260191440A1

A system for detecting oximetry parameters of a user may include a reusable, wireless, and flexible near-infrared spectroscopy (NIRS) monitoring wearable system. The NIRS system may include a first component having a plurality of light sources configured to emit visible and infrared light at a plurality of wavelengths. The first component may have a first detector configured to detect a first plurality of signals from the plurality of light sources at a first source-detector distance of approximately 6 millimeters (mm) to 10 mm. The NIRS system may include a second component having a plurality of second detectors configured to detect a second plurality of signals from the plurality of light sources at multiple source-detector distances ranging from about 25 mm to about 45 mm. The NIRS system may include a memory, rechargeable battery, and processor configured to execute multi-depth tissue analysis.

SYSTEM AND METHOD FOR PROVIDING A DISCRETE WORKSPACE

NºPublicación:  US20260195728A1 09/07/2026
Solicitante: 
MAMAVA INC [US]
Mamava, Inc.
US_20260195728_A1

Resumen de: US20260195728A1

This application describes systems and methods for locating, securing, accessing and utilizing a discrete enclosure or workspace. The discrete enclosure or workspace may be located in a public, private or semi-private setting and may comprise a combination of working platforms or surfaces, seats, desks and other apparatus, as well as computer hardware and software. Systems may comprise natural language processing, artificial intelligence, machine learning and other adaptive learning capabilities to enhance the use of the discrete workspace. The workspace may be dimensioned to be used for a wide variety of activities by one or more users.

MEDICATION ORGANIZER WITH SMART FEATURES

NºPublicación:  WO2026148163A1 09/07/2026
Solicitante: 
RXCAP INC [US]
RXCAP, INC.
WO_2026148163_A1

Resumen de: WO2026148163A1

An article organizer for use with plural articles to be loaded and removed includes a housing including a chamber for removably receiving at least one cartridge, each cartridge removably storing at least one article, an organizer communication module, and an organizer communication module. The housing includes an organizer opening through which the at least one cartridge is insertable into and removable from the housing. The organizer communication module can communicate with the at least one cartridge, and send data to and/or receive data from the at least one cartridge. The organizer controller can process data from the organizer communication module and output information based on the data.

MITIGATION OF COMPRESSION EVENT FAILURE FOR CONTINUOUS GLUCOSE MONITORS

NºPublicación:  AU2024395288A1 09/07/2026
Solicitante: 
DEXCOM INC
DEXCOM, INC
AU_2024395288_PA

Resumen de: AU2024395288A1

Certain aspects of the present disclosure relate to methods and systems for distinguishing between temporary compression of a sensor of a continuous analyte monitoring system and failure of the sensor, such as due to detachment of the sensor. In certain aspects, an apparatus includes an analyte sensor, a temperature sensor, a memory, and a processor communicatively coupled to the memory. The processor is configured to evaluate samples of an output of the analyte sensor and samples of an output of the temperature sensor with respect to a threshold condition. If the threshold condition is met, the processor is configured to generate a signal indicating failure of the analyte sensor.

CLEANING SOLUTION FOR CLEANING AN OBJECT PRODUCED USING A 3D PRINTING METHOD

NºPublicación:  US20260193576A1 09/07/2026
Solicitante: 
SCHMID FRANCA [CH]
SCHMID Franca
US_20260193576_A1

Resumen de: US20260193576A1

0000 The invention relates to a cleaning solution for cleaning an object produced using a 3D printing method, to a method for cleaning an object produced using a 3D printing method by means of the cleaning solution according to the invention, and to the use of the cleaning solution according to the invention to clean an object produced using a 3D printing method. The cleaning solution according to the invention comprises a carbonate and water.

SYSTEMS AND METHODS FOR PERSONALIZED TREATMENT OF CHRONIC PAIN WITH BRAIN-COMPUTER INTERFACE AND MODULAR VIBROTACTILE APPARATUS

NºPublicación:  US20260192078A1 09/07/2026
Solicitante: 
WASHINGTON UNIV [US]
ST LOUIS UNIV [US]
Washington University
St. Louis University
US_20260192078_A1

Resumen de: US20260192078A1

0000 Provided herein is a system for treating chronic pain in a patient, the system including a user computing device including a display screen and a brain-computer interface (BCI) device communicatively coupled to the user computing device. The BCI device includes a processor communicatively coupled to an EEG headset and a vibrotactile device. The processor is configured to (i) prompt, through a display screen, the patient to carry out a plurality of cognitive tasks, the plurality of cognitive tasks selected to create theta activation brainwaves in the patient, (ii) monitor progress of the patient toward reaching a predetermined theta activation goal, (iii) display, through the display screen, a visual feedback via a cue, such as a goal bar, showing the progress of the patient in relation to the predetermined theta activation goal, and (iv) activate, in response to the patient reaching the predetermined theta activation goal, the vibrotactile device to generate multi-modal sensory feedback.

LOAD-CARRYING ROD

NºPublicación:  US20260191565A1 09/07/2026
Solicitante: 
SPINESAVE AG [CH]
SPINESAVE AG
US_20260191565_A1

Resumen de: US20260191565A1

0000 A load-carrying rod for an implant system has a structure of individual interconnected solidified droplets so that the transitions from one droplet to another act as crack stoppers in the event of a crack.

Neuroanatomy-based Search to Optimize Trajectory Selection during DBS Targeting

NºPublicación:  US20260196330A1 09/07/2026
Solicitante: 
BOSTON SCIENT NEUROMODULATION CORPORATION [US]
Boston Scientific Neuromodulation Corporation
US_20260196330_A1

Resumen de: US20260196330A1

0000 Methods and systems for planning a trajectory for implanting electrical stimulation leads in a patient's brain are described. The methods and systems rank candidate trajectories based on their expected therapeutic efficacies, as well as other criteria. Optimized stimulation parameters are determined for each of the candidate trajectories and therapeutic efficacies using the optimized parameters are predicted.

MODEL-BASED COMPENSATION FOR ENHANCED INFUSION PUMP DELIVERY ACCURACY

NºPublicación:  US20260192047A1 09/07/2026
Solicitante: 
CAREFUSION 303 INC [US]
CAREFUSION 303, INC.
US_20260192047_A1

Resumen de: US20260192047A1

0000 An infusion device includes a display and a pump configured for a predetermined volume per mechanical revolution (“VPMR”) under default environmental conditions. The infusion device receives infusion parameters that include (1) a requested flow rate of a fluid to be infused by the infusion device and, and (2) a head height and/or a patient height. The infusion device determines deviated environmental condition values as a function of (1) the received infusion parameters and (2) the default environmental conditions. The infusion device also determines a flow rate accuracy metric as a function of (1) the deviated environmental condition values and (2) an expected performance metric under the default environmental conditions. Responsive to determining the flow rate accuracy metric, the infusion device (a) displays, via the display, an indication of the flow rate accuracy metric; or (b) adjusts an operating speed of the pump based on the flow rate accuracy metric.

ARTICLES AND METHODS FOR DETECTION OF HIDDEN CARDIOVASCULAR DISEASE FROM PORTABLE ELECTROCARDIOGRAPHIC SIGNAL DATA USING DEEP LEARNING

NºPublicación:  US20260196348A1 09/07/2026
Solicitante: 
YALE UNIV [US]
Yale University
US_20260196348_A1

Resumen de: US20260196348A1

Provided herein are methods of training a model to detect cardiovascular disease in a subject from portable electrocardiogram (ECG) signal data and computer-implemented methods of detecting cardiovascular disease in a subject. The methods of training a model includes selecting an ECG dataset corresponding to a cardiovascular disease, the ECG dataset including multiple distinct ECGs, forming a training dataset from the ECG dataset, training the nodes of a deep neural network on the training dataset, and including random gaussian noise with each ECG of the ECG dataset during the training of the nodes. The computer-implemented methods of detecting cardiovascular disease in a subject include applying a deep neural network to ECG data for a subject, the deep neural network being trained according to the training methods disclosed herein.

SPECIMEN CONTAINER FOR ORIENTING AND IMMOBILIZING SPECIMENS DURING IMAGING FOR REDUCED IMAGE ARTIFACTS

NºPublicación:  US20260192299A1 09/07/2026
Solicitante: 
CLARIX IMAGING CORP [US]
CLARIX IMAGING CORPORATION
US_20260192299_A1

Resumen de: US20260192299A1

Improved sample container embodiments are provided for containing and supporting tissue samples during imaging. These sample containers support the samples to prevent distortion due to gravity and/or forces applied on the sample by elements of the container itself. Images generated for the samples thus more accurately reflects the geometry, composition, and orientation of the samples in the body prior to their removal. Such sample containers can include compliant cushions, which may be formed from sheets of material rather than solid volumes of foam or other materials. Such a reduction in cushion material proximate to the sample can result in improved sample imaging. The sample container can also be composed of fluid-impermeable materials to prevent absorption of fluid from the sample, reducing sample deformation and also reducing the imaging of the container material due to absorption of fluid from the sample.

SYSTEMS AND METHODS FOR REAL-TIME PROCESSING OF MEDICAL IMAGING DATA UTILIZING AN EXTERNAL PROCESSING DEVICE

NºPublicación:  US20260195933A1 09/07/2026
Solicitante: 
STRYKER CORP [US]
Stryker Corporation
US_20260195933_A1

Resumen de: US20260195933A1

0000 Described herein are devices for processing surgical video data associated with a surgery and methods of operating the same. An exemplary device includes a housing and a programmable circuit that is enclosed in the housing and configured to receive the surgical video data from a camera control unit. A processor is enclosed in the housing. The processor is communicatively coupled with the programmable circuit and is configured to execute a plurality of instructions for processing the video data stored on a memory. A galvanically isolated connector is exposed on the housing. The galvanically isolated connector is configured to be connected to a surgical device for contact with a patient during the surgery.

PATIENT-SPECIFIC IMPLANT DESIGN AND MANUFACTURING SYSTEM WITH A SURGICAL IMPLANT POSITIONING MANAGER

NºPublicación:  US20260191595A1 09/07/2026
Solicitante: 
CARLSMED INC [US]
Carlsmed, Inc.
US_20260191595_A1

Resumen de: US20260191595A1

Systems and methods for designing and implementing patient-specific surgical procedures and/or medical devices are disclosed. In some embodiments, a method includes receiving intra-operative data during a surgical procedure to install a patient-specific implant in a patient. The system can compare the intra-operative data to a pre-operative plan to determine whether the implant is positioned and located according to the pre-operative plan.

SYSTEM AND METHOD FOR TITRATING BASAL INSULIN DOSES

NºPublicación:  US20260192048A1 09/07/2026
Solicitante: 
DEXCOM INC [US]
Dexcom, Inc.
US_20260192048_A1

Resumen de: US20260192048A1

0000 A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.

SPATIAL AND CHARACTERISTIC PROPERTY DATA TO DETECT A SOURCE IN A SYSTEM

NºPublicación:  US20260191456A1 09/07/2026
Solicitante: 
BIRED IMAGING INC [US]
BIRED Imaging, Inc.
US_20260191456_A1

Resumen de: US20260191456A1

Processes, algorithms and techniques are disclosed for detecting the presence of a source of at least one of heat, mass, momentum, energy, electrical field, and species in a system, such as, for identifying the presence of a heat source and its 3D location within a body part, and also to identify absence of a heat source within the body part. Multi-view thermal images are obtained of the body part and thermal and spatial information in different views are obtained. Iterative algorithms are developed to determine the presence of a heat source in the body part by employing the Physics-Informed Neural Network analyzer. Methods of generating a spatial-point-cloud and thermal-spatial-point-cloud are disclosed.

GLUCOSE LEVEL DEVIATION DETECTION

NºPublicación:  US20260191435A1 09/07/2026
Solicitante: 
DEXCOM INC [US]
Dexcom, Inc.
US_20260191435_A1

Resumen de: US20260191435A1

0000 Glucose level measurements of a user are obtained over time, such as from a wearable glucose monitoring device being worn by the user. These glucose level measurements can be produced substantially continuously, such that the device may be configured to produce the glucose level measurements at regular or irregular intervals of time, responsive to establishing a communicative coupling with a different device, and so forth. These glucose level measurements are analyzed to detect deviations from past glucose measurements, such as glucose measurements received earlier in the day or glucose measurements received at corresponding times of one or more preceding days. Indications of detected deviations are provided to the user or communicated elsewhere, such as to a healthcare professional.

PULMONARY HEALTH MANAGEMENT DEVICE

NºPublicación:  US20260192061A1 09/07/2026
Solicitante: 
PNEUMA RESPIRATORY INC [US]
PNEUMA RESPIRATORY, INC.
US_20260192061_A1

Resumen de: US20260192061A1

An inhalation device includes a housing defining an air flow channel, a pressure sensor configured to detect air flow within the air flow channel, and a piezoelectric driven ejector configured to eject droplets of a fluid into the air flow channel. A controller is electrically coupled to the pressure sensor and the piezoelectric driven ejector. During an initialization phase in which a user takes a set number of deep breaths, the controller determines a trigger point based on measured inhalation flow. The pressure sensor generates a peak inspiratory flow measurement based on a minimum pressure during inhalation and a pulmonary output based on a maximum flow achieved during exhalation. During a dosing inhalation, the controller actuates the piezoelectric driven ejector when the trigger point is reached to dispense a dose of the fluid. The device may further generate pulmonary health management information based on inspiratory and expiratory flow measurements.

Multi-State Engagement With Continuous Glucose Monitoring Systems

Nº publicación: US20260191434A1 09/07/2026

Solicitante:

DEXCOM INC [US]
Dexcom, Inc.

US_20260191434_A1

Resumen de: US20260191434A1

Multi-state engagement with continuous glucose monitoring (CGM) systems is described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains packages of glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform generates state information for the user by processing these CGM packages and the additional data, at least in part, by using one or more models. Based on this state information, the data analytics platform controls communication with the user, which may include generating intervention strategies to prevent users from transitioning to a negative state such as discontinuing use of the CGM system.

traducir